What We're Doing


The coronavirus (COVID-19) outbreak remains a fluid situation. We're continually monitoring our practices to protect the health and safety of all who visit our facilities.

Screening at Entrances

We've established patient and visitor screenings at all our facilities.

Maintaining Special Treatment Areas

COVID-19 patients receive further evaluation, testing, and isolated care in designated treatment areas. All inpatients with COVID-19 are cared for in our separate, new hospital tower. We’re also seeing patients with COVID-19 symptoms in dedicated clinics.

Restricting Access 

We've restricted visitor access to the hospital and our clinics to protect patients and visitors. See the updated visitor guidelines.

Staff that can work remotely are doing so. And we've restricted business visits, volunteers, and other kinds of visitors, too.

Requiring Protective Equipment

All patients and visitors are issued masks when entering our facilities. We continue to ensure our team members wear personal protective equipment (PPE) in accordance with Centers for Disease Control (CDC) guidelines and industry best practices.

Collaborating with Other Experts

We continue to collaborate closely with the Virginia Department of Health and the CDC. We'll coordinate our actions with our public health partners.

Test Development & Vaccine Research

Our researchers are doing everything they can to address the coronavirus outbreak. That includes working on a vaccine and investigating potential treatments. 

COVID-19 Test: Developed

We've developed our own rapid testing for COVID-19. This will speed up our ability to test people with symptoms. Knowing who has the coronavirus is a critical step to slowing its spread.

Only a healthcare provider can decide if you need to get tested. Contact your primary care provider or local clinic if you're having symptoms.

Investigating Coronavirus Treatments

Our scientists are working with their colleagues all over the country to research several potential treatments. We’ve already found that one drug, remdesivir, helps patients recover faster.  

Researchers are also testing the effectiveness of using plasma from recovered patients as a treatment for people hospitalized with COVID-19.